Impairment of Quality of Life among Patients with Wearable Cardioverter Defibrillator Therapy (LifeVest®): A Preliminary Study

BACKGROUND: Wearable cardioverter defibrillator (WCD) therapy is feasible and safe in patients as a transient protection against sudden cardiac death (SCD). However, the impact of WCD therapy on quality of life (QoL) has not been studied. METHODS: In our single-centre study, 109 consecutive patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomed Res Int
Main Authors: Lackermair, Korbinian, Schuhmann, Christoph G., Kubieniec, Michaela, Riesinger, Lisa M., Klier, Ina, Stocker, Thomas J., Kääb, Stefan, Estner, Heidi L., Fichtner, Stephanie
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6040298/
https://ncbi.nlm.nih.gov/pubmed/30050939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6028494
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados